Platelet- rich plasma (PRP) exhibits regenerative proprieties in wound healing but the biochemical mechanisms are unclear. In this study, autologous PRP with a mean value of 338 × 10(3) platelets/µL was used to treat corneal lesions of different aetiology, while homologous PRP with 1 × 10(6) platelets/µL was used to treat cornel lesions induced by a graft versus host disease. The impact of platelet count on the levels of PDGF AA and BB, VEGF, and EGF in the two PRPs was evaluated after a cycle of freezing/thawing. Treated corneal lesions healed or improved. The levels of PDGF AA and BB, VEGF, and EGF in the autologous PRP raised from 296 ± 61; 201.8 ± 24; 53 ± 14 and 8.9 ± 2 to 1017 ± 253; 924.7 ± 222; 101 ± 46.5 and 174 ± 15.5 pg/mL, while in the homologous PRP were 3.4, 4.5, 3.2 and 2 folds higher, respectively. High level of platelet counts seems not required to treat corneal lesions.

Ronci, C., Ferraro, A.s., Lanti, A., Missiroli, F., Sinopoli, S., Del Proposto, G., et al. (2015). Platelet-rich plasma as treatment for persistent ocular epithelial defects. TRANSFUSION AND APHERESIS SCIENCE, 52(3), 300-304 [10.1016/j.transci.2014.12.027].

Platelet-rich plasma as treatment for persistent ocular epithelial defects

Missiroli F.
;
Ricci F.
Membro del Collaboration Group
;
Cudillo L.;Arcese W.;Adorno G.
2015-01-01

Abstract

Platelet- rich plasma (PRP) exhibits regenerative proprieties in wound healing but the biochemical mechanisms are unclear. In this study, autologous PRP with a mean value of 338 × 10(3) platelets/µL was used to treat corneal lesions of different aetiology, while homologous PRP with 1 × 10(6) platelets/µL was used to treat cornel lesions induced by a graft versus host disease. The impact of platelet count on the levels of PDGF AA and BB, VEGF, and EGF in the two PRPs was evaluated after a cycle of freezing/thawing. Treated corneal lesions healed or improved. The levels of PDGF AA and BB, VEGF, and EGF in the autologous PRP raised from 296 ± 61; 201.8 ± 24; 53 ± 14 and 8.9 ± 2 to 1017 ± 253; 924.7 ± 222; 101 ± 46.5 and 174 ± 15.5 pg/mL, while in the homologous PRP were 3.4, 4.5, 3.2 and 2 folds higher, respectively. High level of platelet counts seems not required to treat corneal lesions.
2015
Pubblicato
Rilevanza internazionale
Articolo
Esperti non anonimi
Settore MED/01 - STATISTICA MEDICA
English
Corneal ulcers; Eye drops; Growth factors; Platelet-rich plasma
Ronci, C., Ferraro, A.s., Lanti, A., Missiroli, F., Sinopoli, S., Del Proposto, G., et al. (2015). Platelet-rich plasma as treatment for persistent ocular epithelial defects. TRANSFUSION AND APHERESIS SCIENCE, 52(3), 300-304 [10.1016/j.transci.2014.12.027].
Ronci, C; Ferraro, As; Lanti, A; Missiroli, F; Sinopoli, S; Del Proposto, G; Cipriani, C; De Felici, C; Ricci, F; Ciotti, M; Cudillo, L; Arcese, W; Adorno, G
Articolo su rivista
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/2108/245540
Citazioni
  • ???jsp.display-item.citation.pmc??? 16
  • Scopus 39
  • ???jsp.display-item.citation.isi??? 29
social impact